TOPEKA (AP) – Auditors say they are confident that the Kansas Bioscience Authority is making sound investments and that issues raised by a forensic audit are being addressed.

Members of the Senate Ways and Means Committee heard Tuesday from auditors and the chairman and interim CEO of the KBA about the audit’s findings.

Auditors from BKD Forensics and Valuation Services found instances of document destruction, misuse of funds and a questionable management style by Tom Thornton, who resigned as the
authority’s CEO in April 2011.

Auditors said they found no evidence of conflict of interest in the investments made by the KBA. Authority officials said they were taking the audit’s finding seriously and following recommendations to improve internal controls.